Reports for BAQSIMI
Brand name BAQSIMI |
|---|
Company Name
AMPHASTAR PHARMACEUTICALS, INC.
|
Drug Identification Number
02492415 |
Ingredients
GLUCAGON |
Ingredient Strength
3 MG |
ATC Code
H04AA |
ATC Descriptor
GLYCOGENOLYTIC HORMONES |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| BAQSIMI | 3 mg per container | Resolved | 2024-02-22 | 2024-02-28 | 220276 |
| BAQSIMI | 3 mg glucagon per device | Resolved | 2024-08-20 | 2024-09-23 | 235530 |
| BAQSIMI | 3 mg glucagon per device | Resolved | 2024-10-10 | 2024-10-23 | 239831 |
| BAQSIMI | 3 mg glucagon per device | Resolved | 2024-11-11 | 2024-11-20 | 242464 |
| BAQSIMI | 3 mg glucagon per device | Resolved | 2025-01-06 | 2025-03-19 | 246858 |
| BAQSIMI | 3mg glucagon per device | Resolved | 2025-04-16 | 2025-05-02 | 255162 |
| BAQSIMI | 3mg glucagon per device | Actual shortage | 2025-05-05 | 2025-05-06 | 256705 |
Showing 1 to 7 of 7
Discontinuation reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0